Tekcapital Plc Provides Update on Portfolio Company Salarius, Ltd.
14 Octubre 2021 - 7:35AM
Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF), the UK intellectual
property investment group focused on creating valuable products
from investing in university technology, that can improve people’s
lives, is very pleased to announce that the U.S. Food and Drug
Administration (FDA) has just released voluntary sodium reduction
goals for the food industry.
According to the FDA, these targets were
introduced “to provide measurable voluntary short-term (2.5-year)
goals for sodium content in commercially processed, packaged, and
prepared foods to reduce excess population sodium intake.”i
Dr. Jennifer Ashton, ABC News chief medical
correspondent said “The news from acting FDA Commissioner Janet
Woodcock and Susan T. Mayne, director of the FDA's Center for Food
Safety and Applied Nutrition, could be the biggest, most important
intervention in a generation for public health."ii
This is a significant milestone for Salarius for
the following reasons:
- We believe the FDA guidelines will encourage snack food
manufactures to reduce sodium levels in their products across the
board;
- Salarius anticipates this should have a positive impact on both
B2B sales of MicroSalt® and retail sales of SaltMe! snacks;
- MicroSalt® could be viewed as a timely, nationwide solution, to
help food companies meet these guidelines without sacrificing the
full-flavour of their snack foods, which is key to their successful
on-going sales.
MicroSalt aims to revolutionize the food
industry with its patented sodium microparticle, that delivers the
full-flavour experience of salt with roughly half the sodium.
MicroSalt’s salt particles are approximately 100 times smaller than
regular table salt, allowing them to rapidly dissolve, producing a
large sensation of saltiness. MicroSalt® is all-natural, non-GMO,
and Kosher.
“We’re very excited to see the FDA take a
leadership role in encouraging the food industry to embark on
meaningful sodium reduction programs for their products,” said
Victor Hugo Manzanilla, CEO of MicroSalt. “This is a major
milestone for the country, and we are ready to partner with food
manufacturers to help them comply with the new guidelines whilst
maintaining the full-flavour of their snacks.”
About Salarius Ltd.Salarius, is
the developer and manufacturer of a proprietary low-sodium salt
called MicroSalt®. We are passionate about improving peoples’ lives
with better-for-you snacks by taking the lead in the industry by
providing the best low-sodium salt solution, based on the
mechanical transformation of the salt particle itself. This
solution is the only one that delivers real salt flavor because it
is salt. Our new patented technology produces salt crystals that
are approximately one hundred times smaller than typical table
salt, delivering a powerful saltiness as the micro-grains dissolve
in the mouth, with approximately 50% less sodium consumption.
Additionally, the ultra-small particle size enhances product
adhesion, which reduces waste and provides improved flavor
consistency. MicroSalt® and SaltMe® are registered trademarks of
MicroSalt Inc.
To learn more about MicroSalt please visit
https://Salarius.co/.To learn more about SaltMe! snacks please
visit https://saltme.com/.
Tekcapital owns 97.2% of the share capital of
Salarius Ltd. and 87.1% of the share capital of MicroSalt Inc., its
U.S. subsidiary.
About Tekcapital plc Tekcapital
creates value from investing in new, university-developed
discoveries that can enhance people’s lives and provides a range of
technology transfer services to help organisations evaluate and
commercialise new technologies. Tekcapital is quoted on the AIM
market of the London Stock Exchange (AIM: symbol TEK) and is
headquartered in the UK. For more information, please visit
www.tekcapital.com.
Forward Looking Statements &
DisclaimerThis press release is for informational purposes
only. The information herein does not constitute investment advice
nor an offer to invest and may contain statements related to our
future business and financial performance and future events or
developments involving Tekcapital that may constitute
forward-looking statements. These statements may be identified by
words such as "expect," "look forward to," "anticipate" "intend,"
"plan," "believe," "seek," "estimate," "will," "project" or words
of similar meaning. We may also make forward-looking statements in
other reports, in presentations, on social media, in material
delivered to customers, stakeholders and in press releases. In
addition, our representatives may from time to time make oral
forward-looking statements. Such statements may be based on the
current expectations and certain assumptions of Tekcapital’s
management. Please note that these are subject to a number of
risks, uncertainties and factors, including, but not limited to
those described in various disclosures. Should one or more of these
risks or uncertainties materialize, or should underlying
expectations not occur or assumptions prove incorrect, actual
results, performance or achievements of Tekcapital may vary
materially from those described explicitly or implicitly in the
relevant forward-looking statement. Forward-looking statements
express, as at the date of this release, the Company’s plans,
estimates, valuations, forecasts, projections, opinions,
expectations or beliefs as to future events, results or
performance. Forward-looking statements involve a number of risks
and uncertainties, many of which are beyond the Company’s control,
including those associated with COVID-19, and there can be no
assurance that such statements will prove to be accurate. No
assurance is given that such forward looking statements or views
are correct or that the objectives of the Company will be achieved.
Further, valuations of Company’s portfolio investments and net
asset value can and will fluctuate over time due to a variety of
factors and this could have a material negative impact on the
Company’s financial performance. Tekcapital neither intends, nor
assumes any obligation, to update or revise these forward-looking
statements in light of developments which may differ from those
anticipated.
i
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-voluntary-sodium-reduction-goals
ii
https://www.goodmorningamerica.com/food/story/fda-recommends-restaurants-food-manufacturers-cut-back-salt-80554477
For further information, please contact:
Tekcapital Plc
Via Skyline
Clifford M. Gross, Ph.D.
Skyline Corporate Communications Group, LLC (U.S.)
Matthew Abenante/Scott Powell
+1 646 893 5835
Tekcapital (LSE:TEK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Tekcapital (LSE:TEK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024